When should we start screening for hydroxychloroquine retinopathy?

Rheumatology (Oxford). 2022 Aug 3;61(8):3097-3098. doi: 10.1093/rheumatology/keac043.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Fluorescein Angiography
  • Humans
  • Hydroxychloroquine / adverse effects
  • Retinal Diseases* / chemically induced
  • Retinal Diseases* / diagnosis
  • Tomography, Optical Coherence

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine